Views & Analysis Coronavirus pharma news roundup – 14/08/20 Catch up on the latest coronavirus vaccine and digital tech news in our roundup of this week’s biggest stories.
Views & Analysis Novo Nordisk: Prevention, digital tools and collaboration to... In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he
Views & Analysis Coronavirus pharma news roundup - 07/08/20 Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales.
Views & Analysis How does HTA for orphan drugs differ across Europe? New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines across Europe.
Views & Analysis Preparing for an influx of cell and gene therapy approvals Cell and gene therapies offer some of the most groundbreaking advancements in patient care the pharma industry has ever seen.
Views & Analysis Coronavirus pharma news roundup – 31/07/20 Vaccines, AI-driven drug discovery and llamas all hit the headlines this week as the search for a way to end the COVID-19 pandemic continues.
News Court sides with EU on decision to revoke Ocaliva's license Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
